Savara announces participation in jefferies global healthcare conference

Langhorne, pa.--(business wire)--savara inc. (nasdaq: svra) (the company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced members of the management team will host 1x1 meetings and present at the jefferies global healthcare conference on june 4, 2025, at 9:20am et/6:20am pt. the live webcast and subsequent replay will be available on the “events & presentations” section of the company's corporate website and will be archived for 90 days. abou.
SVRA Ratings Summary
SVRA Quant Ranking